Results for tag: "CNS Marker"

Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease or condition. The Central Nervous System (CNS) Marker market is a subset of the biomarker market that focuses on the development of biomarkers for neurological diseases and disorders. CNS Markers are used to diagnose, monitor, and treat neurological diseases and disorders, such as Alzheimer’s, Parkinson’s, and Multiple Sclerosis. They are also used to measure the effectiveness of treatments and to predict the risk of developing neurological diseases. CNS Markers are typically proteins, peptides, or metabolites that are found in the cerebrospinal fluid, blood, or other bodily fluids. They can be used to detect the presence of a neurological disorder, to monitor the progression of the disorder, and to measure the effectiveness of treatments. Some companies in the CNS Marker market include Bio-Rad Laboratories, Bio-Techne, and Abcam. Other companies include Bio-Techne, Abcam, and Bio-Rad Laboratories. Show Less Read more